Basal insulin hypersecretion in insulin-resistant Zucker diabetic and Zucker fatty rats: Role of enhanced fuel metabolism

Metabolism: Clinical and Experimental

Volumn 48, Issue 7, 1999, Pages 857-864

  Zhou, Yun Ping ^a   Cockburn, Brian N ^a   Pugh, William ^a   Polonsky, Kenneth S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZOXIDE; FATTY ACID; FUEL; GLUCOSE; INSULIN; OLIGOMYCIN; ROTENONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FATTY ACID OXIDATION; GLYCOLYSIS; HYPERINSULINEMIA; INSULIN METABOLISM; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN RESPONSE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT;

EID: 0032993726     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90219-6     Document Type: Article

References (41)

1. Leahy JL, Weir GC: Unresponsiveness to glucose in a streptozotocin model of diabetes, inappropriate insulin and glucagon responses to a reduction of glucose concentration. Diabetes 34:653-659, 1985
2. Tokuyama Y, Sturis J, DePaoli AM, et al: Evolution of β-cell dysfunction in the male Zucker diabetic fatty rat. Diabetes 44:1447-1457, 1995
3. Ohneda M, Johnson JH, Lee YH, et al: Post-GLUT-2 defects in β-cells of non-insulin dependent diabetic obese rats. Am J Physiol 267:E968-E974, 1994
4. Ohneda M, Inman LR, Unger RH: Caloric restriction in obese pre-diabetic rats prevents beta-cell depletion, loss of beta-cell Glut 2 and glucose incompetence. Diabetologia 38:173-179, 1995
5. Unger RH: Lipotoxicity in the pathogenesis of obesity-dependent NIDDM, genetic and clinical implications. Diabetes 44:863-870, 1995
6. Zhou YP, Grill VE: Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and bio-synthesis through a glucose fatty acid cycle. J Clin Invest 93:870-876, 1994
7. Lee Y, Hirose H, Ohneda M, et al: β-Cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: Impairment in adipocyte-β-cell relationships. Proc Natl Acad Sci USA 91:10878-10882, 1994
8. Portha B, Serradas P, Bailbe D, et al: β-Cell insensitivity to glucose in the GK rat, a spontaneous nonobese model for type II diabetes. Diabetes 40:486-491, 1991
9. Leahy JL, Bonner-Weir S, Weir GC: Abnormal glucose regulation of insulin secretion in models of reduced B-cell mass. Diabetes 33:667-673, 1984
10. Malaisse WJ, Marynissen G, Senor A: Possible role of glycogen accumulation in B-cell glucotoxicity. Metabolism 41:814-819, 1992
11. Leahy JL: Impaired β-cell function with chronic hyperglycemia: "Overworked β-cell" hypothesis. Diabetes Rev 4:298-319, 1996
12. Becker TC, BeltrandelRio H, Neol RJ, et al: Overexpression of hexokinase I in isolated islets of Langerhans via recombinant adenovirus: Enhancement of glucose metabolism and insulin secretion at basal but not stimulatory glucose levels. J Biol Chem 269:21234-21238, 1994
13. Cockburn BN, Ostrega DM, Kubstrup C, et al: Changes in pancreatic islet glucokinase and hexokinase activities with increasing age, obesity, and the onset of diabetes. Diabetes 46:1434-1439, 1997
14. Halban PA: Proinsulin processing in the regulated and the constitutive secretory pathway. Diabetologia 37:S65-S72, 1994 (suppl)
15. Martin Thomas FJ: Stages of regulated exocytosis. Trend Cell Biol 7:271-276, 1997
16. Sreenan S, Sturis J, Pugh W, et al: Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment with metformin or troglitazone. Am J Physol 271:E742-E747, 1996
17. Lacy PE, Kostianovsky M: Method for the isolation of intact islet of Langerhans from the rat pancreas. Diabetes 16:35-39, 1967
18. Zhou YP, Priestman DA, Randle PJ, et al: Fasting and decreased B cell sensitivity: Important role for fatty acid-induced inhibition of PDH activity. Am J Physiol 270:E988-E994, 1996
19. Smeekens SP, Montag AG, Thomas G, et al: Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2, and PC3. Proc Natl Acad Sci USA 89:8822-8826, 1992
20. Martin SK, Carroll R, Benig M, et al: Regulation by glucose of the biosynthesis of PC2, PC3 and proinsulin in (ob/ob) mouse islets of Langerhans. FEBS Lett 356:279-292, 1994
21. Sturis J, Pugh WL, Tang J, et al: Alterations in pulsatile insulin secretion in the Zucker diabetic fatty rat. Am J Physiol 267:E250-E259, 1994
22. Labarca C, Paigen K: A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 102:344-352, 1980
23. Zawalich WS, Pagliara AS, Matschinsky FM: Effect of iodoacetate, mannoheptulose and 3-O-methyl glucose on the secretory function and metabolism of isolated islets. Endocrinology 100:1276-1282, 1977
24. German MS: Glucose sensing in pancreatic islet beta cells: The key role of glucokinase and the glycolytic intermediate. Proc Natl Acad Sci USA 90:1781-1785, 1993
25. Mertz RJ, Worley JF III, Spencer B, et al: Activation of stimulus-secretion coupling in pancreatic β-cell by specific products of glucose metabolism: Evidence for privileged signaling by glycolysis. J Biol Chem 271:4838-4845, 1996
26. Anderson RC, Balestra M, Bell PA, et al: Antidiabetic agents: A new class of reversible carnitine palmitoyltransferase I inhibitors. J Med Chem 38:3448-3450, 1995
27. Newgard CB, McGarry JD: Metabolic coupling factors in pancreatic β-cell signal transduction. Annu Rev Biochem 64:689-719, 1995
28. + channel in mouse pancreatic β-cells. Pflugers Arch 407:493-499, 1986
29. Renström E, Eliasson L, et al: Cooling inhibits exocytosis in single mouse pancreatic B-cells by suppression of granule mobilization. J Physiol (Lond) 494:41-52, 1996
30. 2+ channel activity. Am J Physol 270:E133-E140, 1996
31. Jirousek MR, Gilig JR, Gonzalez CM, et al: (S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16,21-dimethyleno-1H, 13H-dibenzol [e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3 (2H)-dione (LY333531) and related analogues: Isozyme selective inhibitors of protein kinase Cβ. J Med Chem 39:2664-2671, 1996
32. Straub SG, Sharp GW: A Wortmannin-sensitive signal transduction pathway is involved in the stimulation of insulin release by vasoactive intestinal polypeptide and pituitary adenylate cyclaseactivating polypeptide. J Biol Chem 271:1660-1668, 1996
33. 2+-channel activity in mouse pancreatic beta-cells stimulated with calmidazolium (compound R24571). FEBS Lett 369: 315-320, 1995
34. Leibel RL, Chung WK, Chua SC Jr: The molecular genetics of rodent single gene obesities. J Biol Chem 272:31937-31940, 1997
35. Pick A, Clark J, Kubstrup C, et al: Role of apoptosis in failure of β-cell mass compensation for insulin resistance and β-cell defects in the male Zucker diabetic fatty rat. Diabetes 47:358-364, 1998
36. Rhodes CJ, Alarcon C: What β-cell defect could lead to hyperproinsulinemia in NIDDM? Some clues from recent advances made in understanding the proinsulin-processing mechanism. Diabetes 43:511-517, 1994
37. Prentki M, Corkey BE: Are the β-cell signaling molecules malonyl-CoA and cytosolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? Diabetes 45:273-283, 1996
38. Hosokawa H, Corkey BE, Leahy JL: Beta-cell hypersensitivity to glucose following 24-h exposure of rat islets to fatty acids. Diabetologia 40:392-397, 1997
39. Bollheimer LC, Skelly R, Chester MW, et al: Chronic exposure to free fatty acid reduces pancreatic β-cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation. J Clin Invest 101:1094-1101, 1998
40. Skelly RH, Bollheimer LC, Wicksteed BL, et al: A distinct difference in the metabolic stimulus-response coupling pathways for regulating proinsulin biosynthesis and insulin secretion that lies at the level of a requirement for fatty acyl moieties. Biochem J 331:553-561, 1998
41. Huang XF, Arvan P: Intracellular transport of proinsulin in pancreatic β-cells, structural maturation probed by disulfide accessibility. J Biol Chem 270:20417-20423, 1996